Conference focused on Transparency and Engagement with Healthcare Professionals, hosted by Informa Connect
On August 12, from 11:15am to 12:00pm, a fireside chat titled "Enforcement Update - Examining Today's Regulatory Landscape and Emerging Trends" will take place at Informa Connect's Transparency & HCP Engagement Conference. This event brings together Pharma and MedTech visionaries, providing a platform for insightful discussions.
The session, led by Amanda Masselam Strachan, will focus on analyzing the current regulatory landscape and recent enforcement actions impacting the life sciences industry. It will also delve into understanding the latest guidance and expectations for effective compliance programs.
Key points likely to be discussed include current regulatory enforcement activities and trends, challenges in maintaining compliance amid evolving regulations, best practices for compliance programs, the use of data analytics and benchmarking, and emerging trends such as AI and technology solutions that improve compliance monitoring and audit coverage.
The chat will also examine upcoming areas of regulatory focus for 2025 and beyond. While the exact session transcript is not detailed in search results, speakers Amanda Masselam Strachan and Lauren Kootman, Principal Assistant Deputy Chief, Corporate Enforcement & Compliance Unit, Fraud Section of the DOJ, are known for their expertise in enforcement and compliance, suggesting a focus on actionable legal and regulatory insights for transparency in pharmaceutical and healthcare sectors.
It is important to note that this session will not cover the participation of Lauren Kootman, the topic of HCP engagement, compliance monitoring, data reporting and governance, or the topic of the Transparency & HCP Engagement Conference again, as these were already mentioned earlier.
This session aligns with conference themes addressing enforcement updates, regulatory landscape changes, and the integration of advanced compliance tools for HCP engagement management. The event does not specify its location. The discussion will not be repeated, making it a unique opportunity for industry professionals to gain valuable insights into the latest regulatory developments.
[1] Source for conference themes: [Link to source 1] [2] Source for speakers' expertise: [Link to source 2] [3] Source for conference agenda: [Link to source 3] [4] Source for broader discussions: [Link to source 4]
Read also:
- Treatment Options for Uterine Cancer: An Overview
- Instructions for Encouraging a Dementia Sufferer to Clean Their Teeth
- Government intends to enforce medical certificates for cannabis users to prevent illicit exportation
- Gunman at CDC links COVID-19 vaccine to depression; labor union calls for anti-misinformation declaration
